(Q41099743)

26 September 2017

0 references

Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses (English)

1 reference

26 September 2017

0 references

0 references

0 references

0 references

1 reference

Liang Shen

1

1 reference

PubMed ID

25854931

26 September 2017

Hong-Fang Ji

series ordinal

2

1 reference

26 September 2017

8 April 2015

1 reference

Journal of Alzheimer's Disease

26 September 2017

1 reference

26 September 2017

46

1 reference

26 September 2017

3

1 reference

26 September 2017

777-790

1 reference

Forecasting the global burden of Alzheimer’s disease

26 September 2017

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Prevalence of dementia in the United States: the aging, demographics, and memory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Testing the right target and right drug at the right stage

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

The projected effect of risk factor reduction on Alzheimer's disease prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Homocysteine and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Biochemical markers and risk factors of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Hyperhomocysteinemia in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Relation between plasma homocysteine and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Homocysteine, vitamin B6, and vascular disease in AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Homocysteine in Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

A cross-sectional study of homocysteine-, NO-levels, and CT-findings in Alzheimer dementia, vascular dementia and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Homocysteine and B vitamins in mild cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer's disease in mild cognitive impairment: a 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Alzheimer's disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

CSF/serum folate gradient: physiology and determinants with special reference to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Elevated serum homocysteine level is not associated with serum C-reactive protein in patients with probable Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Fasting and post-methionine homocysteine levels in Alzheimers disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Homocysteine, vitamin B 12 and folate in Alzheimer's and vascular dementias: the paradoxical effect of the superimposed type II diabetes mellitus condition

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Serum folate concentrations in patients with cortical and subcortical dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Role of vitamin B(12), folate, and thyroid stimulating hormone in dementia: A hospital-based study in north Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

CSF-folate levels are decreased in late-onset AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Dietary factors and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Vitamin B(12) and folate in relation to the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Neurodegenerative diseases and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Does disturbed homocysteine and folate metabolism in depression result from enhanced oxidative stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

21 January 2018

Homocysteine and stroke

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Abeta peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Homocysteine and brain atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

Platelet MAO-B activity and vitamin B12 in old age dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150140

21 January 2018

Identifiers

DOI

10.3233/JAD-150140

1 reference

26 September 2017

1 reference

PubMed ID

25854931